News
Dr. Marty Makary, the agency’s commissioner, has said too many women avoid menopause treatments because the risks have been ...
The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...
US Food and Drug Administration Commissioner Marty Makary signaled Thursday that he is open to revising strict warning labels ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
News Nation on MSN1h
FDA considers changing HRT warning, among 'greatest mistakes' in medicine: Commissioner | Elizabeth Vargas ReportsThe FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...
FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
Nearly six months into President Trump’s second term, The Hill and NewsNation team up to host the inaugural Hill Nation ...
The US could scrap warnings on hormone replacement therapy (HRT) in a major shake-up of the treatment for menopause.
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results